• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,935.00(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ANG Lifesciences India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70392.0
  • ISIN : INE236W01016
27.00 -1 (-2.56%)
  • As on 25 Apr 2025 (EOD)

  • Today’s Low

    26.37

  • Today’s High

    28.69

  • Open

    28.69

  • Perv Close

    27.71

  • 52W Low

    21.03

  • 52W High

    62.75

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    35.26

  • Div & Yield %

    0.00

  • Book Value(₹)

    56.15

  • Debt-Equity Ratio

    -2.56

  • AGM Date

    25-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.88

  • Mar.Cap (₹Cr.)

    35.26

  • RONW (%)

    -10.56

  • ROCE (%)

    1.43

Score Board

  • Equity (₹ in Cr.)

    13.06

  • BV (₹)

    56.20

  • Sales( ₹ in Cr.)

    131.37

  • NP (in Cr.)

    -7.08

  • NP Var(%)

    -1707.0

  • Div%

    0.0

  • CPS (₹)

    0.50

  • EPS (₹)

    -5.40

  • Traded Value (₹ in Lakhs)

    36.18

  • 52 Week High

    62.75

  • 52 Week Low

    21.03

  • Price BSE

    28.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    36.18

  • P/C Ratio

    54.50

  • P/E Ratio

    -5.20

  • Price Vs.BV

    -5.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 131.37 207.01 348.67 154.28 126.83 121.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 131.37 207.01 348.67 154.28 126.83 121.70
Other Income 0.84 9.84 0.95 0.75 0.42 0.23
Stock Adjustments 6.74 4.22 4.47 4.30 0.59 1.05
Total Income 138.95 221.07 354.09 159.33 127.84 122.98
EXPENDITURE :            
Raw Materials 93.93 151.12 234.49 108.26 89.56 88.89
Power and Fuel Cost 3.61 5.99 5.68 4.88 3.66 2.71
Employee Cost 15.90 20.27 18.32 14.35 7.10 6.39
Other Manufacturing Expenses 0.91 1.85 2.96 1.60 1.03 0.80
Selling and Administration Expenses 13.04 18.21 23.49 13.56 10.60 8.73
Miscellaneous Expenses 2.89 2.12 2.65 0.59 3.04 3.58
Employee Benefit Expenses 15.90 20.27 18.32 14.35 7.10 6.39
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 130.28 199.56 287.60 143.24 114.99 111.10
Operating Profit 8.66 21.51 66.49 16.08 12.85 11.87
Interest 9.77 10.92 8.31 3.98 3.22 2.64
Gross Profit -1.11 10.59 58.18 12.10 9.63 9.23
Depreciation 7.75 8.52 5.12 2.24 1.23 1.12
Profit Before Tax -8.86 2.07 53.06 9.86 8.40 8.11
Current Tax 0.00 2.11 13.47 3.18 2.40 2.43
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.22 0.62 -0.11 -0.57 -0.09 0.03
Reported Net Profit -8.65 -0.66 39.71 7.25 6.10 5.65
Extraordinary Items -1.56 -0.27 0.00 0.00 0.00 0.00
Adjusted Net Profit -7.09 -0.39 39.71 7.25 6.10 5.65
Adjustment below Net Profit 0.19 0.72 0.21 -0.70 -0.26 0.00
P & L Balance brought forward 63.16 63.10 24.22 17.67 13.03 7.38
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -4.33 0.00 1.04 0.00 0.00 0.00
P & L Balance carried down 59.02 63.16 63.10 24.22 18.87 13.03
Dividend 0.00 0.00 1.04 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 10.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 1.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -6.62 -0.51 38.31 13.99 11.76 10.90
Earnings Per Share(Adj)-Unit Curr -6.62 -0.51 30.65 5.60 4.70 4.36
Book Value 58.74 61.91 76.00 76.99 66.67 55.50
Book Value(Adj)-Unit Curr 58.74 61.91 60.80 30.80 26.67 22.20

Shareholding Pattern

  • Promoter Group

    70.60%

  • Public Share Holding

    29.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,219,537 70.60 9,219,537 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,219,537 70.60 9,219,537 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 28,016 0.21 28,016 17
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 245,792 1.88 245,792 77
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 749,377 5.74 749,377 23
Individuals holding nominal share capital up to Rs. 1 lakh 2,660,332 20.37 2,655,782 6,285
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 155,233 1.19 155,233 104
Sub Total 3,838,750 29.40 3,834,200 6,506
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,058,287 100.00 13,053,737 6,508

Company Background

ANG Lifesciences India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • ANG Lifesciences India Ltd
  • BSE Code : 70392.0
  • ISIN : INE236W01016

  • Incorporation Year

    2006

  • Registered Office

    Darbara Complex SCO 113 I Flr
    Dist. Shopping Centre B Block, Amritsar,
    Punjab-143001

  • Telephone

    91-0183-5070118/5070119

  • FAX

  • Chairman

  • Managing Director

    Rajesh Gupta

  • Company Secretary

    Harshita Aggarwal

  • Auditor

    Khurana Sharma & Co/Raman Wadhwa & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

ANG Lifesciences India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ANG Lifesciences 27.00 132.20 131.37 -2.93 1.71
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92